Start free

Hepion Pharmaceuticals, Inc. (HEPA) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 27, 2026.

Filings shown
23
Open-market buys
7
Open-market sells
0
Buys, 10b5-1 box not checked
7 of 7

Counts cover the 23 most recent Form 4 filings Tradune holds for HEPA (filed Aug 12 – Oct 27, 2026); the score below covers only the trailing 90 days (0 buys, 0 sells). SEC EDGAR Form 4 filings for HEPA last checked Nov 21, 2026, 09:00 UTC; the latest HEPA filing Tradune holds was filed Oct 27, 2026. This is not guaranteed to be the complete record — see HEPA's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for HEPA filed Sep 10 – Oct 27, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Danina FisherDirector 1 0 200,000 — +$10,000

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

No notable activity
0 distinct buyers0 buy · 0 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at HEPA

Insiders reported 7 open-market purchases of HEPA between Aug 12, 2026 and Oct 27, 2026, across 6 distinct buyers. The most recent purchase was reported by Danina Fisher (Director) on Sep 29, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

James Gordon Liddy Director · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 510,000 — — — Oct 23, 2026
Danina Fisher Director · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 510,000 — — — Oct 23, 2026
Gary S. Stetz Chief Financial Officer · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,530,000 — — — Oct 23, 2026
Vincent S. LoPriore Executive Chairman · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,530,000 — — — Oct 23, 2026
Michael J. Purcell Director · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 510,000 — — — Oct 23, 2026
Sireesh Appajosyula Chief Executive Officer · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,530,000 — — — Oct 23, 2026
Chase LoPriore VP, Corp. Dev. · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,530,000 — — — Oct 23, 2026
Gary S. Stetz II Director · filed Oct 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 510,000 — — — Oct 23, 2026
Danina Fisher Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Derivative purchase Warrants 200,000 — — — Sep 29, 2026
Open-market purchase 10b5-1 box not checked 200,000 $0.05 200,000 — Sep 29, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Vincent S. LoPriore Executive Chairman · filed Sep 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Derivative purchase Warrants 12,500,000 — — — Sep 3, 2026
Michael J. Purcell Director · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 299,000 — — — Aug 19, 2026
Gary S. Stetz Interim CEO · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,345,500 — — — Aug 19, 2026
Vincent S. LoPriore Executive Chairman · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,345,500 — — — Aug 19, 2026
Chase LoPriore VP, Corp. Dev. · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,345,500 — — — Aug 19, 2026
Danina Fisher Director · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 299,000 — — — Aug 19, 2026
James Gordon Liddy Director · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 299,000 — — — Aug 19, 2026
Sireesh Appajosyula Chief Operating Officer · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,345,500 — — — Aug 19, 2026
Gary S. Stetz II Director · filed Aug 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 299,000 — — — Aug 19, 2026
Gary S. Stetz II Director · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 500,000 $0.05 500,000 — Aug 3, 2026
Derivative purchase Warrants 500,000 — — — Aug 3, 2026
Gary S. Stetz Interim CEO · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000,000 $0.05 3,250,000 +160% Aug 3, 2026
Derivative purchase Warrants 2,000,000 — — — Aug 3, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Michael J. Purcell Director · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000,000 $0.05 3,250,000 +160% Aug 3, 2026
Derivative purchase Warrants 2,000,000 — — — Aug 3, 2026
Sireesh Appajosyula Chief Operating Officer · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000,000 $0.05 3,250,000 +160% Aug 3, 2026
Derivative purchase Warrants 2,000,000 — — — Aug 3, 2026
Vincent S. LoPriore Executive Chairman · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000,000 $0.05 16,250,000 (indirect) +14% Aug 3, 2026
Open-market purchase 10b5-1 box not checked 8,000,000 $0.05 14,250,000 (indirect) +128% Aug 3, 2026
Derivative purchase Warrants 8,000,000 — — — Aug 3, 2026
Derivative purchase Warrants 2,000,000 — — — Aug 3, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to HEPA's (Oct 27, 2026).

Frequently asked about HEPA insider activity

How many insiders bought HEPA stock in these Form 4 filings?

6 distinct insiders at Hepion Pharmaceuticals, Inc. reported 7 open-market purchases (Form 4 code P) of HEPA shares between Aug 12, 2026 and Oct 27, 2026, the most recent filed by Danina Fisher (Director) on Sep 29, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for HEPA?

The most recent Form 4 on this page was filed by Gary S. Stetz II (Director) on Oct 27, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market HEPA insider purchase shown?

The largest open-market purchase among the filings shown was 8,000,000 HEPA shares at $0.05 (about $400,000) by Vincent S. LoPriore (Executive Chairman) on Aug 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent HEPA insider purchases have the Form 4 10b5-1 box checked?

No. All 7 HEPA open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Danina Fisher (Director) on Sep 29, 2026, 200,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for HEPA — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.